Treasurer of the State of North Carolina boosted its holdings in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 69,707 shares of the health services provider’s stock after purchasing an additional 890 shares during the period. Treasurer of the State of North Carolina’s holdings in Teladoc Health were worth $1,649,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of TDOC. Oliver Lagore Vanvalin Investment Group boosted its holdings in Teladoc Health by 94.3% in the third quarter. Oliver Lagore Vanvalin Investment Group now owns 1,030 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 500 shares during the last quarter. Concord Wealth Partners purchased a new position in Teladoc Health in the fourth quarter valued at about $46,000. Harvest Fund Management Co. Ltd purchased a new position in Teladoc Health in the fourth quarter valued at about $67,000. Householder Group Estate & Retirement Specialist LLC boosted its holdings in Teladoc Health by 17.1% in the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 3,062 shares of the health services provider’s stock valued at $72,000 after purchasing an additional 448 shares during the last quarter. Finally, Ronald Blue Trust Inc. boosted its holdings in Teladoc Health by 814.5% in the fourth quarter. Ronald Blue Trust Inc. now owns 2,908 shares of the health services provider’s stock valued at $74,000 after purchasing an additional 2,590 shares during the last quarter. Hedge funds and other institutional investors own 84.14% of the company’s stock.
Teladoc Health Stock Down 1.5 %
Shares of TDOC stock opened at $23.78 on Friday. Teladoc Health, Inc. has a 1 year low of $21.60 and a 1 year high of $44.66. The business’s fifty day moving average is $25.55 and its 200-day moving average is $26.76. The company has a current ratio of 3.37, a quick ratio of 3.25 and a debt-to-equity ratio of 0.67.
Analysts Set New Price Targets
TDOC has been the topic of a number of research analyst reports. Oppenheimer reduced their target price on Teladoc Health from $37.00 to $35.00 and set an “outperform” rating on the stock in a report on Thursday, February 23rd. JPMorgan Chase & Co. reduced their target price on Teladoc Health from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Monday, February 27th. Deutsche Bank Aktiengesellschaft increased their target price on Teladoc Health from $27.00 to $29.00 in a report on Friday, April 28th. Wells Fargo & Company reduced their target price on Teladoc Health from $28.00 to $23.00 and set an “equal weight” rating on the stock in a report on Monday, March 6th. Finally, Stephens initiated coverage on Teladoc Health in a report on Tuesday, April 11th. They set an “equal weight” rating and a $25.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, seventeen have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $32.78.
Insider Activity
In other news, insider Arnnon Geshuri sold 1,090 shares of Teladoc Health stock in a transaction on Monday, February 27th. The stock was sold at an average price of $26.69, for a total transaction of $29,092.10. Following the transaction, the insider now directly owns 73,227 shares in the company, valued at approximately $1,954,428.63. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, insider Arnnon Geshuri sold 1,090 shares of Teladoc Health stock in a transaction on Monday, February 27th. The stock was sold at an average price of $26.69, for a total value of $29,092.10. Following the transaction, the insider now directly owns 73,227 shares in the company, valued at approximately $1,954,428.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Adam C. Vandervoort sold 3,877 shares of Teladoc Health stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $25.36, for a total value of $98,320.72. Following the completion of the transaction, the insider now owns 15,629 shares in the company, valued at $396,351.44. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 58,423 shares of company stock worth $1,514,860. 1.63% of the stock is owned by company insiders.
About Teladoc Health
Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services.
Featured Stories
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
- Foot Locker And The Ebbing Tide Of Discretionary Spending
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
